ROBERT TRICHTER: Open Payments
NPI 1629019468 · CULVER CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 18 payments from 5 companies in 2025. Trend: 2023 $609 · 2024 $890 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $152 |
| Neurocrine BioSciences, Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: ARISTADA, INGREZZA, CAPLYTA, FANAPT, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
